Dr. Regine Junie Mathieu, MD

Dr. Mathieu practices at Kathleen L Behr M D Inc in Fresno, California.

Dr. Mathieu's NPI, 1285130401, was assigned on April 5, 2018. Dr. Mathieu graduated from New York Medical College in 2017. Dr. Mathieu's Rhode Island license number on file is LP04775.

Dr. Mathieu's primary practice is Kathleen L Behr M D Inc, at 1125 E Spruce Ave, Fresno, CA 93720 in Fresno County. The practice phone is (559) 435-7546.

Dr. Mathieu's primary practice is Kathleen L Behr M D Inc in Fresno, California. The medical group on file is Behr Laser & Skin Care Center. Dmand AI also links Dr. Mathieu to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mathieu practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Mathieu's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Mathieu is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Mathieu's licenses on file in 2 states: Rhode Island and California.

Dmand AI lists scalp rash among the conditions Dr. Mathieu treats.

CMS data shows 313 Medicare services from Dr. Mathieu across 9 procedure codes in 2024, for 130 Medicare patients. Medicare paid $21,127 for them. Every service was in an office.

CMS counts 130 Medicare patients who saw Dr. Mathieu in 2024. The largest group is 75 to 84, with 69 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mathieu's median patient age at 53, with 88% women.

In 2024, Dr. Mathieu wrote 194 Medicare Part D claims for 75 patients. 97% of them were for generic drugs. CMS names the drug for 100 of them, across 6 drugs with 11 or more claims each, at $1,752 in total drug cost. In 2022, CMS named 51 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 59 out of 100 for Dr. Mathieu for performance year 2024, reported as part of a group. Dr. Mathieu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 145 procedures of removal of skin lesions by Dr. Mathieu, more than 77% of the clinicians it reports for that procedure.

Removal of skin cancer: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Mathieu, published from 2017 to 2023. 2022 was the busiest year, with 3. The most frequent topics are Melanoma. Dr. Mathieu has published most often in JAAD Case Rep. Dr. Mathieu's most frequent co-authors are Edward Bae, MD, Elnaz F. Firoz, MD and Solomiya Grushchak, MD.

CMS Open Payments shows 73 general payments to Dr. Mathieu from 8 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 62% of the total. Merz North America, Inc. paid the most, $2,665.

Dr. Mathieu graduated from New York Medical College in 2017.

Dr. Mathieu is in network with 2 carriers, including CMS Medicare and RI State Medicaid. Medicaid plans come from the most carriers, 1. Check the plan with the practice before a visit.